Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

Reasons to be Cheerful reports that cycling improves focus in kids, especially those with ADHD, as seen in Spooner Middle School's successful Riding for Focus program.

LLVM powers the core development tools, operating systems, and most applications at Apple Computer, where it long ago ...

The Transportation Security Administration is initiating a new screening program for crew members, and airlines are paying ...

Baby’s first piece of Americana? Millions of newborns arriving during America’s 250th birthday celebration will receive a ...

A pre-wedding video showing Pune realtor Ketan Agarwal joyfully celebrating with his fiancée Siya Goyal and her parents has ...

July-August 2026 The July issue of Supply Chain Management Review explores how organizations are preparing for the future ...

ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA’s lead BiTAC-TCE program toward IND/CTA-enabling activities ...

Bocunebart's PACAP-targeting mechanism positions it as a potential first-in-class therapy in a thin pipeline of novel ...

Beauty's next frontier isn't a product, it's brain health, with science-backed rituals reshaping skincare and a wellness ...

Don't buy a "borrowed science" NAD supplement. Discover how Niagen Bioscience’s patented NR safely and efficiently boosts ...

The IRS has fundamentally changed how it enforces tax compliance. As of June 2025, the agency operates 126 active AI use cases, up from just 10 in August 2022, spanning audit sele ...